Immune Tolerance Network (UM1 Clinical Trial Required)

The purpose of this notice of funding opportunity (NOFO) is to support applications to continue the Immune Tolerance Network (ITN). The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases and asthma; 2) Autoimmune diseases; and 3) Immune-mediated consequences of transplantation. The core functions of the ITN include designing, conducting, and sharing the results of clinical trials and performing integrated mechanistic studies.

Education

• Independent school districts
• Public and state institutions of higher education
• Private institutions of higher education

Government

• Public and Indian housing authorities
• Federally recognized Native American tribal governments
• State governments
• City or township governments
• County governments
• Special district governments

Nonprofit

• Nonprofits non-higher education with 501(c)(3)
• Nonprofits non-higher education without 501(c)(3)
• Other Native American tribal organizations

Miscellaneous

• Other

Business

• For-profit organizations other than small businesses
• Small businesses